 | • レポートコード：MRC2-11QY03703 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はカルベトシン（デュラトシン）のグローバル市場について調査・分析したレポートです。種類別（錠剤、注射）市場規模、用途別（子宮収縮剤、止血剤、子宮収縮剤）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別カルベトシン（デュラトシン）の競争状況、市場シェア ・世界のカルベトシン（デュラトシン）市場：種類別市場規模 2015年-2020年（錠剤、注射） ・世界のカルベトシン（デュラトシン）市場：種類別市場規模予測 2021年-2026年（錠剤、注射） ・世界のカルベトシン（デュラトシン）市場：用途別市場規模 2015年-2020年（子宮収縮剤、止血剤、子宮収縮剤） ・世界のカルベトシン（デュラトシン）市場：用途別市場規模予測 2021年-2026年（子宮収縮剤、止血剤、子宮収縮剤） ・北米のカルベトシン（デュラトシン）市場分析：米国、カナダ ・ヨーロッパのカルベトシン（デュラトシン）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのカルベトシン（デュラトシン）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のカルベトシン（デュラトシン）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのカルベトシン（デュラトシン）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Beacon Pharmaceuticals Limited、Ferring Inc.、Polypeptide Laboraries France、Chemos GmbH & Co. KG、Hangzhou Dayangchem Co. Ltd.、Acinopeptide Co., Ltd.、Bachem AG、Clearsynth Canada INC.、Leap Labchem Co., Ltd、Chemieliva Pharmaceutical Co., Ltd.、Acinopeptide Co., Ltd.、BOC Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Carbetocin (Duratocin) Market
The global Carbetocin (Duratocin) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Carbetocin (Duratocin) Scope and Market Size
Carbetocin (Duratocin) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Carbetocin (Duratocin) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Carbetocin (Duratocin) market is segmented into
Tablets
Injection
Segment by Application, the Carbetocin (Duratocin) market is segmented into
Oxytocic
Antihemorrhagic
Uterotonic
Regional and Country-level Analysis
The Carbetocin (Duratocin) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Carbetocin (Duratocin) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Carbetocin (Duratocin) Market Share Analysis
Carbetocin (Duratocin) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Carbetocin (Duratocin) business, the date to enter into the Carbetocin (Duratocin) market, Carbetocin (Duratocin) product introduction, recent developments, etc.
The major vendors covered:
Beacon Pharmaceuticals Limited
Ferring Inc.
Polypeptide Laboraries France
Chemos GmbH & Co. KG
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Bachem AG
Clearsynth Canada INC.
Leap Labchem Co., Ltd
Chemieliva Pharmaceutical Co., Ltd.
Acinopeptide Co., Ltd.
BOC Sciences
1 Study Coverage
1.1 Carbetocin (Duratocin) Product Introduction
1.2 Market Segments
1.3 Key Carbetocin (Duratocin) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Carbetocin (Duratocin) Market Size Growth Rate by Type
1.4.2 Tablets
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Carbetocin (Duratocin) Market Size Growth Rate by Application
1.5.2 Oxytocic
1.5.3 Antihemorrhagic
1.5.4 Uterotonic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Carbetocin (Duratocin) Market Size, Estimates and Forecasts
2.1.1 Global Carbetocin (Duratocin) Revenue 2015-2026
2.1.2 Global Carbetocin (Duratocin) Sales 2015-2026
2.2 Global Carbetocin (Duratocin), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Carbetocin (Duratocin) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Carbetocin (Duratocin) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Carbetocin (Duratocin) Competitor Landscape by Players
3.1 Carbetocin (Duratocin) Sales by Manufacturers
3.1.1 Carbetocin (Duratocin) Sales by Manufacturers (2015-2020)
3.1.2 Carbetocin (Duratocin) Sales Market Share by Manufacturers (2015-2020)
3.2 Carbetocin (Duratocin) Revenue by Manufacturers
3.2.1 Carbetocin (Duratocin) Revenue by Manufacturers (2015-2020)
3.2.2 Carbetocin (Duratocin) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Carbetocin (Duratocin) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Carbetocin (Duratocin) Revenue in 2019
3.2.5 Global Carbetocin (Duratocin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Carbetocin (Duratocin) Price by Manufacturers
3.4 Carbetocin (Duratocin) Manufacturing Base Distribution, Product Types
3.4.1 Carbetocin (Duratocin) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Carbetocin (Duratocin) Product Type
3.4.3 Date of International Manufacturers Enter into Carbetocin (Duratocin) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Carbetocin (Duratocin) Market Size by Type (2015-2020)
4.1.1 Global Carbetocin (Duratocin) Sales by Type (2015-2020)
4.1.2 Global Carbetocin (Duratocin) Revenue by Type (2015-2020)
4.1.3 Carbetocin (Duratocin) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Carbetocin (Duratocin) Market Size Forecast by Type (2021-2026)
4.2.1 Global Carbetocin (Duratocin) Sales Forecast by Type (2021-2026)
4.2.2 Global Carbetocin (Duratocin) Revenue Forecast by Type (2021-2026)
4.2.3 Carbetocin (Duratocin) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Carbetocin (Duratocin) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Carbetocin (Duratocin) Market Size by Application (2015-2020)
5.1.1 Global Carbetocin (Duratocin) Sales by Application (2015-2020)
5.1.2 Global Carbetocin (Duratocin) Revenue by Application (2015-2020)
5.1.3 Carbetocin (Duratocin) Price by Application (2015-2020)
5.2 Carbetocin (Duratocin) Market Size Forecast by Application (2021-2026)
5.2.1 Global Carbetocin (Duratocin) Sales Forecast by Application (2021-2026)
5.2.2 Global Carbetocin (Duratocin) Revenue Forecast by Application (2021-2026)
5.2.3 Global Carbetocin (Duratocin) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Carbetocin (Duratocin) by Country
6.1.1 North America Carbetocin (Duratocin) Sales by Country
6.1.2 North America Carbetocin (Duratocin) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Carbetocin (Duratocin) Market Facts & Figures by Type
6.3 North America Carbetocin (Duratocin) Market Facts & Figures by Application
7 Europe
7.1 Europe Carbetocin (Duratocin) by Country
7.1.1 Europe Carbetocin (Duratocin) Sales by Country
7.1.2 Europe Carbetocin (Duratocin) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Carbetocin (Duratocin) Market Facts & Figures by Type
7.3 Europe Carbetocin (Duratocin) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Carbetocin (Duratocin) by Region
8.1.1 Asia Pacific Carbetocin (Duratocin) Sales by Region
8.1.2 Asia Pacific Carbetocin (Duratocin) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Carbetocin (Duratocin) Market Facts & Figures by Type
8.3 Asia Pacific Carbetocin (Duratocin) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Carbetocin (Duratocin) by Country
9.1.1 Latin America Carbetocin (Duratocin) Sales by Country
9.1.2 Latin America Carbetocin (Duratocin) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Carbetocin (Duratocin) Market Facts & Figures by Type
9.3 Central & South America Carbetocin (Duratocin) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Carbetocin (Duratocin) by Country
10.1.1 Middle East and Africa Carbetocin (Duratocin) Sales by Country
10.1.2 Middle East and Africa Carbetocin (Duratocin) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Carbetocin (Duratocin) Market Facts & Figures by Type
10.3 Middle East and Africa Carbetocin (Duratocin) Market Facts & Figures by Application
11 Company Profiles
11.1 Beacon Pharmaceuticals Limited
11.1.1 Beacon Pharmaceuticals Limited Corporation Information
11.1.2 Beacon Pharmaceuticals Limited Description and Business Overview
11.1.3 Beacon Pharmaceuticals Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Products Offered
11.1.5 Beacon Pharmaceuticals Limited Related Developments
11.2 Ferring Inc.
11.2.1 Ferring Inc. Corporation Information
11.2.2 Ferring Inc. Description and Business Overview
11.2.3 Ferring Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ferring Inc. Carbetocin (Duratocin) Products Offered
11.2.5 Ferring Inc. Related Developments
11.3 Polypeptide Laboraries France
11.3.1 Polypeptide Laboraries France Corporation Information
11.3.2 Polypeptide Laboraries France Description and Business Overview
11.3.3 Polypeptide Laboraries France Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Polypeptide Laboraries France Carbetocin (Duratocin) Products Offered
11.3.5 Polypeptide Laboraries France Related Developments
11.4 Chemos GmbH & Co. KG
11.4.1 Chemos GmbH & Co. KG Corporation Information
11.4.2 Chemos GmbH & Co. KG Description and Business Overview
11.4.3 Chemos GmbH & Co. KG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Chemos GmbH & Co. KG Carbetocin (Duratocin) Products Offered
11.4.5 Chemos GmbH & Co. KG Related Developments
11.5 Hangzhou Dayangchem Co. Ltd.
11.5.1 Hangzhou Dayangchem Co. Ltd. Corporation Information
11.5.2 Hangzhou Dayangchem Co. Ltd. Description and Business Overview
11.5.3 Hangzhou Dayangchem Co. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Products Offered
11.5.5 Hangzhou Dayangchem Co. Ltd. Related Developments
11.6 Acinopeptide Co., Ltd.
11.6.1 Acinopeptide Co., Ltd. Corporation Information
11.6.2 Acinopeptide Co., Ltd. Description and Business Overview
11.6.3 Acinopeptide Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Products Offered
11.6.5 Acinopeptide Co., Ltd. Related Developments
11.7 Bachem AG
11.7.1 Bachem AG Corporation Information
11.7.2 Bachem AG Description and Business Overview
11.7.3 Bachem AG Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bachem AG Carbetocin (Duratocin) Products Offered
11.7.5 Bachem AG Related Developments
11.8 Clearsynth Canada INC.
11.8.1 Clearsynth Canada INC. Corporation Information
11.8.2 Clearsynth Canada INC. Description and Business Overview
11.8.3 Clearsynth Canada INC. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Clearsynth Canada INC. Carbetocin (Duratocin) Products Offered
11.8.5 Clearsynth Canada INC. Related Developments
11.9 Leap Labchem Co., Ltd
11.9.1 Leap Labchem Co., Ltd Corporation Information
11.9.2 Leap Labchem Co., Ltd Description and Business Overview
11.9.3 Leap Labchem Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Leap Labchem Co., Ltd Carbetocin (Duratocin) Products Offered
11.9.5 Leap Labchem Co., Ltd Related Developments
11.10 Chemieliva Pharmaceutical Co., Ltd.
11.10.1 Chemieliva Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Chemieliva Pharmaceutical Co., Ltd. Description and Business Overview
11.10.3 Chemieliva Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Products Offered
11.10.5 Chemieliva Pharmaceutical Co., Ltd. Related Developments
11.1 Beacon Pharmaceuticals Limited
11.1.1 Beacon Pharmaceuticals Limited Corporation Information
11.1.2 Beacon Pharmaceuticals Limited Description and Business Overview
11.1.3 Beacon Pharmaceuticals Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Products Offered
11.1.5 Beacon Pharmaceuticals Limited Related Developments
11.12 BOC Sciences
11.12.1 BOC Sciences Corporation Information
11.12.2 BOC Sciences Description and Business Overview
11.12.3 BOC Sciences Sales, Revenue and Gross Margin (2015-2020)
11.12.4 BOC Sciences Products Offered
11.12.5 BOC Sciences Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Carbetocin (Duratocin) Market Estimates and Projections by Region
12.1.1 Global Carbetocin (Duratocin) Sales Forecast by Regions 2021-2026
12.1.2 Global Carbetocin (Duratocin) Revenue Forecast by Regions 2021-2026
12.2 North America Carbetocin (Duratocin) Market Size Forecast (2021-2026)
12.2.1 North America: Carbetocin (Duratocin) Sales Forecast (2021-2026)
12.2.2 North America: Carbetocin (Duratocin) Revenue Forecast (2021-2026)
12.2.3 North America: Carbetocin (Duratocin) Market Size Forecast by Country (2021-2026)
12.3 Europe Carbetocin (Duratocin) Market Size Forecast (2021-2026)
12.3.1 Europe: Carbetocin (Duratocin) Sales Forecast (2021-2026)
12.3.2 Europe: Carbetocin (Duratocin) Revenue Forecast (2021-2026)
12.3.3 Europe: Carbetocin (Duratocin) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Carbetocin (Duratocin) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Carbetocin (Duratocin) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Carbetocin (Duratocin) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Carbetocin (Duratocin) Market Size Forecast by Region (2021-2026)
12.5 Latin America Carbetocin (Duratocin) Market Size Forecast (2021-2026)
12.5.1 Latin America: Carbetocin (Duratocin) Sales Forecast (2021-2026)
12.5.2 Latin America: Carbetocin (Duratocin) Revenue Forecast (2021-2026)
12.5.3 Latin America: Carbetocin (Duratocin) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Carbetocin (Duratocin) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Carbetocin (Duratocin) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Carbetocin (Duratocin) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Carbetocin (Duratocin) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Carbetocin (Duratocin) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Carbetocin (Duratocin) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Carbetocin (Duratocin) Market Segments
Table 2. Ranking of Global Top Carbetocin (Duratocin) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Carbetocin (Duratocin) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Tablets
Table 5. Major Manufacturers of Injection
Table 6. Global Carbetocin (Duratocin) Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Carbetocin (Duratocin) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Carbetocin (Duratocin) Sales by Regions 2015-2020 (K Units)
Table 9. Global Carbetocin (Duratocin) Sales Market Share by Regions (2015-2020)
Table 10. Global Carbetocin (Duratocin) Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Carbetocin (Duratocin) Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Carbetocin (Duratocin) Sales Share by Manufacturers (2015-2020)
Table 13. Global Carbetocin (Duratocin) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Carbetocin (Duratocin) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carbetocin (Duratocin) as of 2019)
Table 15. Carbetocin (Duratocin) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Carbetocin (Duratocin) Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Carbetocin (Duratocin) Price (2015-2020) (USD/Unit)
Table 18. Carbetocin (Duratocin) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Carbetocin (Duratocin) Product Type
Table 20. Date of International Manufacturers Enter into Carbetocin (Duratocin) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Carbetocin (Duratocin) Sales by Type (2015-2020) (K Units)
Table 23. Global Carbetocin (Duratocin) Sales Share by Type (2015-2020)
Table 24. Global Carbetocin (Duratocin) Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Carbetocin (Duratocin) Revenue Share by Type (2015-2020)
Table 26. Carbetocin (Duratocin) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Carbetocin (Duratocin) Sales by Application (2015-2020) (K Units)
Table 28. Global Carbetocin (Duratocin) Sales Share by Application (2015-2020)
Table 29. North America Carbetocin (Duratocin) Sales by Country (2015-2020) (K Units)
Table 30. North America Carbetocin (Duratocin) Sales Market Share by Country (2015-2020)
Table 31. North America Carbetocin (Duratocin) Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Carbetocin (Duratocin) Revenue Market Share by Country (2015-2020)
Table 33. North America Carbetocin (Duratocin) Sales by Type (2015-2020) (K Units)
Table 34. North America Carbetocin (Duratocin) Sales Market Share by Type (2015-2020)
Table 35. North America Carbetocin (Duratocin) Sales by Application (2015-2020) (K Units)
Table 36. North America Carbetocin (Duratocin) Sales Market Share by Application (2015-2020)
Table 37. Europe Carbetocin (Duratocin) Sales by Country (2015-2020) (K Units)
Table 38. Europe Carbetocin (Duratocin) Sales Market Share by Country (2015-2020)
Table 39. Europe Carbetocin (Duratocin) Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Carbetocin (Duratocin) Revenue Market Share by Country (2015-2020)
Table 41. Europe Carbetocin (Duratocin) Sales by Type (2015-2020) (K Units)
Table 42. Europe Carbetocin (Duratocin) Sales Market Share by Type (2015-2020)
Table 43. Europe Carbetocin (Duratocin) Sales by Application (2015-2020) (K Units)
Table 44. Europe Carbetocin (Duratocin) Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Carbetocin (Duratocin) Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Carbetocin (Duratocin) Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Carbetocin (Duratocin) Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Carbetocin (Duratocin) Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Carbetocin (Duratocin) Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Carbetocin (Duratocin) Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Carbetocin (Duratocin) Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Carbetocin (Duratocin) Sales Market Share by Application (2015-2020)
Table 53. Latin America Carbetocin (Duratocin) Sales by Country (2015-2020) (K Units)
Table 54. Latin America Carbetocin (Duratocin) Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Carbetocin (Duratocin) Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Carbetocin (Duratocin) Revenue Market Share by Country (2015-2020)
Table 57. Latin America Carbetocin (Duratocin) Sales by Type (2015-2020) (K Units)
Table 58. Latin America Carbetocin (Duratocin) Sales Market Share by Type (2015-2020)
Table 59. Latin America Carbetocin (Duratocin) Sales by Application (2015-2020) (K Units)
Table 60. Latin America Carbetocin (Duratocin) Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Carbetocin (Duratocin) Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Carbetocin (Duratocin) Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Carbetocin (Duratocin) Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Carbetocin (Duratocin) Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Carbetocin (Duratocin) Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Carbetocin (Duratocin) Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Carbetocin (Duratocin) Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Carbetocin (Duratocin) Sales Market Share by Application (2015-2020)
Table 69. Beacon Pharmaceuticals Limited Corporation Information
Table 70. Beacon Pharmaceuticals Limited Description and Major Businesses
Table 71. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Beacon Pharmaceuticals Limited Product
Table 73. Beacon Pharmaceuticals Limited Recent Development
Table 74. Ferring Inc. Corporation Information
Table 75. Ferring Inc. Description and Major Businesses
Table 76. Ferring Inc. Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Ferring Inc. Product
Table 78. Ferring Inc. Recent Development
Table 79. Polypeptide Laboraries France Corporation Information
Table 80. Polypeptide Laboraries France Description and Major Businesses
Table 81. Polypeptide Laboraries France Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Polypeptide Laboraries France Product
Table 83. Polypeptide Laboraries France Recent Development
Table 84. Chemos GmbH & Co. KG Corporation Information
Table 85. Chemos GmbH & Co. KG Description and Major Businesses
Table 86. Chemos GmbH & Co. KG Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Chemos GmbH & Co. KG Product
Table 88. Chemos GmbH & Co. KG Recent Development
Table 89. Hangzhou Dayangchem Co. Ltd. Corporation Information
Table 90. Hangzhou Dayangchem Co. Ltd. Description and Major Businesses
Table 91. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Hangzhou Dayangchem Co. Ltd. Product
Table 93. Hangzhou Dayangchem Co. Ltd. Recent Development
Table 94. Acinopeptide Co., Ltd. Corporation Information
Table 95. Acinopeptide Co., Ltd. Description and Major Businesses
Table 96. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Acinopeptide Co., Ltd. Product
Table 98. Acinopeptide Co., Ltd. Recent Development
Table 99. Bachem AG Corporation Information
Table 100. Bachem AG Description and Major Businesses
Table 101. Bachem AG Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Bachem AG Product
Table 103. Bachem AG Recent Development
Table 104. Clearsynth Canada INC. Corporation Information
Table 105. Clearsynth Canada INC. Description and Major Businesses
Table 106. Clearsynth Canada INC. Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Clearsynth Canada INC. Product
Table 108. Clearsynth Canada INC. Recent Development
Table 109. Leap Labchem Co., Ltd Corporation Information
Table 110. Leap Labchem Co., Ltd Description and Major Businesses
Table 111. Leap Labchem Co., Ltd Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Leap Labchem Co., Ltd Product
Table 113. Leap Labchem Co., Ltd Recent Development
Table 114. Chemieliva Pharmaceutical Co., Ltd. Corporation Information
Table 115. Chemieliva Pharmaceutical Co., Ltd. Description and Major Businesses
Table 116. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Chemieliva Pharmaceutical Co., Ltd. Product
Table 118. Chemieliva Pharmaceutical Co., Ltd. Recent Development
Table 119. Acinopeptide Co., Ltd. Corporation Information
Table 120. Acinopeptide Co., Ltd. Description and Major Businesses
Table 121. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Acinopeptide Co., Ltd. Product
Table 123. Acinopeptide Co., Ltd. Recent Development
Table 124. BOC Sciences Corporation Information
Table 125. BOC Sciences Description and Major Businesses
Table 126. BOC Sciences Carbetocin (Duratocin) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. BOC Sciences Product
Table 128. BOC Sciences Recent Development
Table 129. Global Carbetocin (Duratocin) Sales Forecast by Regions (2021-2026) (K Units)
Table 130. Global Carbetocin (Duratocin) Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Carbetocin (Duratocin) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Carbetocin (Duratocin) Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Carbetocin (Duratocin) Sales Forecast by Country (2021-2026) (K Units)
Table 134. North America: Carbetocin (Duratocin) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Carbetocin (Duratocin) Sales Forecast by Country (2021-2026) (K Units)
Table 136. Europe: Carbetocin (Duratocin) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Carbetocin (Duratocin) Sales Forecast by Region (2021-2026) (K Units)
Table 138. Asia Pacific: Carbetocin (Duratocin) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Carbetocin (Duratocin) Sales Forecast by Country (2021-2026) (K Units)
Table 140. Latin America: Carbetocin (Duratocin) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Carbetocin (Duratocin) Sales Forecast by Country (2021-2026) (K Units)
Table 142. Middle East and Africa: Carbetocin (Duratocin) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Carbetocin (Duratocin) Players
Table 147. Carbetocin (Duratocin) Customers List
Table 148. Carbetocin (Duratocin) Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Carbetocin (Duratocin) Product Picture
Figure 2. Global Carbetocin (Duratocin) Sales Market Share by Type in 2020 & 2026
Figure 3. Tablets Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Carbetocin (Duratocin) Sales Market Share by Application in 2020 & 2026
Figure 6. Oxytocic
Figure 7. Antihemorrhagic
Figure 8. Uterotonic
Figure 9. Carbetocin (Duratocin) Report Years Considered
Figure 10. Global Carbetocin (Duratocin) Market Size 2015-2026 (US$ Million)
Figure 11. Global Carbetocin (Duratocin) Sales 2015-2026 (K Units)
Figure 12. Global Carbetocin (Duratocin) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Carbetocin (Duratocin) Sales Market Share by Region (2015-2020)
Figure 14. Global Carbetocin (Duratocin) Sales Market Share by Region in 2019
Figure 15. Global Carbetocin (Duratocin) Revenue Market Share by Region (2015-2020)
Figure 16. Global Carbetocin (Duratocin) Revenue Market Share by Region in 2019
Figure 17. Global Carbetocin (Duratocin) Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Carbetocin (Duratocin) Revenue in 2019
Figure 19. Carbetocin (Duratocin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Carbetocin (Duratocin) Sales Market Share by Type (2015-2020)
Figure 21. Global Carbetocin (Duratocin) Sales Market Share by Type in 2019
Figure 22. Global Carbetocin (Duratocin) Revenue Market Share by Type (2015-2020)
Figure 23. Global Carbetocin (Duratocin) Revenue Market Share by Type in 2019
Figure 24. Global Carbetocin (Duratocin) Market Share by Price Range (2015-2020)
Figure 25. Global Carbetocin (Duratocin) Sales Market Share by Application (2015-2020)
Figure 26. Global Carbetocin (Duratocin) Sales Market Share by Application in 2019
Figure 27. Global Carbetocin (Duratocin) Revenue Market Share by Application (2015-2020)
Figure 28. Global Carbetocin (Duratocin) Revenue Market Share by Application in 2019
Figure 29. North America Carbetocin (Duratocin) Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Carbetocin (Duratocin) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Carbetocin (Duratocin) Sales Market Share by Country in 2019
Figure 32. North America Carbetocin (Duratocin) Revenue Market Share by Country in 2019
Figure 33. U.S. Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Carbetocin (Duratocin) Market Share by Type in 2019
Figure 38. North America Carbetocin (Duratocin) Market Share by Application in 2019
Figure 39. Europe Carbetocin (Duratocin) Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Carbetocin (Duratocin) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Carbetocin (Duratocin) Sales Market Share by Country in 2019
Figure 42. Europe Carbetocin (Duratocin) Revenue Market Share by Country in 2019
Figure 43. Germany Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Carbetocin (Duratocin) Market Share by Type in 2019
Figure 54. Europe Carbetocin (Duratocin) Market Share by Application in 2019
Figure 55. Asia Pacific Carbetocin (Duratocin) Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Carbetocin (Duratocin) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Carbetocin (Duratocin) Sales Market Share by Region in 2019
Figure 58. Asia Pacific Carbetocin (Duratocin) Revenue Market Share by Region in 2019
Figure 59. China Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Carbetocin (Duratocin) Market Share by Type in 2019
Figure 82. Asia Pacific Carbetocin (Duratocin) Market Share by Application in 2019
Figure 83. Latin America Carbetocin (Duratocin) Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Carbetocin (Duratocin) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Carbetocin (Duratocin) Sales Market Share by Country in 2019
Figure 86. Latin America Carbetocin (Duratocin) Revenue Market Share by Country in 2019
Figure 87. Mexico Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Carbetocin (Duratocin) Market Share by Type in 2019
Figure 94. Latin America Carbetocin (Duratocin) Market Share by Application in 2019
Figure 95. Middle East and Africa Carbetocin (Duratocin) Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Carbetocin (Duratocin) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Carbetocin (Duratocin) Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Carbetocin (Duratocin) Revenue Market Share by Country in 2019
Figure 99. Turkey Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Carbetocin (Duratocin) Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Carbetocin (Duratocin) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Carbetocin (Duratocin) Market Share by Type in 2019
Figure 106. Middle East and Africa Carbetocin (Duratocin) Market Share by Application in 2019
Figure 107. North America Carbetocin (Duratocin) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Carbetocin (Duratocin) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Carbetocin (Duratocin) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Carbetocin (Duratocin) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Carbetocin (Duratocin) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Carbetocin (Duratocin) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Carbetocin (Duratocin) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Carbetocin (Duratocin) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Carbetocin (Duratocin) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Carbetocin (Duratocin) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
子宮収縮剤の世界市場（～2026年） Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding…- ガソリン直噴（GDI）の世界市場（～2026年） Market Analysis and Insights: Global Gasoline Direct Injection (GDI) Market The global Gasoline Direct Injection (GDI) market size is projected to reach US$ 8631.5 million by 2026, from US$ 7851.4 million in 2020, at a CAGR of 9.2%% during 2021-2026. Global Gasoline Direct Injection (GDI) Scope and …
- 粉末射出成形（PIM）の世界市場（～2026年） Market Analysis and Insights: Global Powder Injection Molding（PIM） Market The global Powder Injection Molding（PIM） market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Powder Injection Molding（PIM） Scope and Market Size Pow…
- タブレット用ジェスチャー認識の世界市場（～2026年） Gesture recognition is the ability of a device to identify and respond to different gestures, such as movement of hands, fingers, arms, head, or the entire body, of an individual. In gesture recognition technology, a remotely-controlled device can be ideally operated using certain gestures, such as …
- 粉末射出成形の世界市場（～2026年） Injection Molding is a type of manufacturing technology that can use either metals or ceramics to produce small yet geometrically complex shapes that are widely used in end-user industries like the consumer products and medical devices. The adoption of leading-edge process control and monitoring sys…